Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.

Hølmebakk T, Bjerkehagen B, Hompland I, Stoldt S, Boye K.

Br J Surg. 2018 Dec 3. doi: 10.1002/bjs.11027. [Epub ahead of print]

PMID:
30507040
2.

Multimodal kreftbehandling av gastrointestinal stromal tumor.

Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS.

Tidsskr Nor Laegeforen. 2018 Oct 1;138(15). doi: 10.4045/tidsskr.18.0200. Print 2018 Oct 2. Norwegian.

3.

Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor.

Namløs HM, Boye K, Mishkin SJ, Barøy T, Lorenz S, Bjerkehagen B, Stratford EW, Munthe E, Kudlow BA, Myklebost O, Meza-Zepeda LA.

Mol Cancer Ther. 2018 Nov;17(11):2473-2480. doi: 10.1158/1535-7163.MCT-18-0174. Epub 2018 Aug 10.

PMID:
30097488
4.

Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53.

Høland M, Kolberg M, Danielsen SA, Bjerkehagen B, Eilertsen IA, Hektoen M, Mandahl N, van den Berg E, Smeland S, Mertens F, Sundby Hall K, Picci P, Sveen A, Lothe RA.

Mod Pathol. 2018 Nov;31(11):1694-1707. doi: 10.1038/s41379-018-0074-y. Epub 2018 Jun 26.

PMID:
29946184
5.

Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).

Sundby Hall K, Bruland ØS, Bjerkehagen B, Zaikova O, Engellau J, Hagberg O, Hansson L, Hagberg H, Ahlström M, Knobel H, Papworth K, Zemmler M, Goplen D, Bauer HCF, Eriksson M.

Eur J Cancer. 2018 Aug;99:78-85. doi: 10.1016/j.ejca.2018.05.011. Epub 2018 Jun 19.

PMID:
29929092
6.

Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples.

Kresse SH, Namløs HM, Lorenz S, Berner JM, Myklebost O, Bjerkehagen B, Meza-Zepeda LA.

PLoS One. 2018 May 17;13(5):e0197456. doi: 10.1371/journal.pone.0197456. eCollection 2018.

7.

Cytogenetics of Spindle Cell/Pleomorphic Lipomas: Karyotyping and FISH Analysis of 31 Tumors.

Panagopoulos I, Gorunova L, Lund-Iversen M, Andersen K, Andersen HK, Lobmaier I, Bjerkehagen B, Heim S.

Cancer Genomics Proteomics. 2018 May-Jun;15(3):193-200.

8.

Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.

Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K.

Ann Surg Oncol. 2018 May;25(5):1133-1139. doi: 10.1245/s10434-018-6353-5. Epub 2018 Feb 12.

PMID:
29435684
9.

Genotype and risk of tumour rupture in gastrointestinal stromal tumour.

Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T.

Br J Surg. 2018 Jan;105(2):e169-e175. doi: 10.1002/bjs.10743.

PMID:
29341147
10.

Consistent Involvement of Chromosome 13 in Angiolipoma.

Panagopoulos I, Gorunova L, Andersen K, Lobmaier I, Bjerkehagen B, Heim S.

Cancer Genomics Proteomics. 2018 Jan-Feb;15(1):61-65.

11.

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.

Ferrari S, Bielack SS, Smeland S, Longhi A, Egerer G, Sundby Hall K, Donati D, Kevric M, Brosjö O, Comandone A, Werner M, Monge O, Palmerini E, Berdel WE, Bjerkehagen B, Paioli A, Lorenzen S, Eriksson M, Gambarotti M, Tunn PU, Jebsen NL, Cesari M, von Kalle T, Ferraresi V, Schwarz R, Bertulli R, Kasparek AK, Grignani G, Krasniqi F, Sorg B, Hecker-Nolting S, Picci P, Reichardt P.

Tumori. 2018 Jan-Feb;104(1):30-36. doi: 10.5301/tj.5000696.

PMID:
29218692
12.

Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.

Behjati S, Tarpey PS, Haase K, Ye H, Young MD, Alexandrov LB, Farndon SJ, Collord G, Wedge DC, Martincorena I, Cooke SL, Davies H, Mifsud W, Lidgren M, Martin S, Latimer C, Maddison M, Butler AP, Teague JW, Pillay N, Shlien A, McDermott U, Futreal PA, Baumhoer D, Zaikova O, Bjerkehagen B, Myklebost O, Amary MF, Tirabosco R, Van Loo P, Stratton MR, Flanagan AM, Campbell PJ.

Nat Commun. 2017 Jun 23;8:15936. doi: 10.1038/ncomms15936.

13.

Genetic heterogeneity in leiomyomas of deep soft tissue.

Panagopoulos I, Gorunova L, Brunetti M, Agostini A, Andersen HK, Lobmaier I, Bjerkehagen B, Heim S.

Oncotarget. 2017 Jul 25;8(30):48769-48781. doi: 10.18632/oncotarget.17953.

14.

Identification of SETD2-NF1 fusion gene in a pediatric spindle cell tumor with the chromosomal translocation t(3;17)(p21;q12).

Panagopoulos I, Gorunova L, Lobmaier I, Bjerkehagen B, Heim S.

Oncol Rep. 2017 Jun;37(6):3181-3188. doi: 10.3892/or.2017.5628. Epub 2017 May 4.

15.

Cytogenetic Analysis of a Pseudoangiomatous Pleomorphic/Spindle Cell Lipoma.

Panagopoulos I, Gorunova L, Lobmaier I, Andersen HK, Bjerkehagen B, Heim S.

Anticancer Res. 2017 May;37(5):2219-2223.

PMID:
28476785
16.

The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma.

Trovik C, Bauer HCF, Styring E, Sundby Hall K, Vult Von Steyern F, Eriksson S, Johansson I, Sampo M, Laitinen M, Kalén A, Jónsson H Jr, Jebsen N, Eriksson M, Tukiainen E, Wall N, Zaikova O, Sigurðsson H, Lehtinen T, Bjerkehagen B, Skorpil M, Egil Eide G, Johansson E, Alvegard TA.

Acta Orthop. 2017 Jun;88(3):341-347. doi: 10.1080/17453674.2017.1293441. Epub 2017 Mar 7.

17.

Loss of chromosome 13 material in cellular angiofibromas indicates pathogenetic similarity with spindle cell lipomas.

Panagopoulos I, Gorunova L, Bjerkehagen B, Andersen K, Lund-Iversen M, Heim S.

Diagn Pathol. 2017 Feb 13;12(1):17. doi: 10.1186/s13000-017-0607-6.

18.

Karyotyping and analysis of GNAS locus in intramuscular myxomas.

Panagopoulos I, Gorunova L, Lobmaier I, Bjerkehagen B, Heim S.

Oncotarget. 2017 Mar 28;8(13):22086-22094. doi: 10.18632/oncotarget.14986.

19.

Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report.

Namløs HM, Zaikova O, Bjerkehagen B, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA.

BMC Cancer. 2017 Jan 6;17(1):29. doi: 10.1186/s12885-016-2992-8.

20.

Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years.

König M, Osnes TA, Lobmaier I, Bjerkehagen B, Bruland ØS, Sundby Hall K, Meling TR.

Neurosurg Rev. 2017 Jul;40(3):449-460. doi: 10.1007/s10143-016-0802-z. Epub 2016 Nov 17.

PMID:
27858303
21.

Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas.

Panagopoulos I, Gorunova L, Lund-Iversen M, Lobmaier I, Bjerkehagen B, Heim S.

Mod Pathol. 2016 Nov;29(11):1415-1423. doi: 10.1038/modpathol.2016.129. Epub 2016 Jul 29.

22.

Molecular characterization of the t(4;12)(q27~28;q14~15) chromosomal rearrangement in lipoma.

Agostini A, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S, Panagopoulos I.

Oncol Lett. 2016 Sep;12(3):1701-1704. Epub 2016 Jul 8.

23.

Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine.

Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby Hall K.

Br J Surg. 2016 May;103(6):684-691. doi: 10.1002/bjs.10104. Epub 2016 Mar 14.

PMID:
26988241
24.

Fusion of the HMGA2 and C9orf92 genes in myolipoma with t(9;12)(p22;q14).

Panagopoulos I, Gorunova L, Agostini A, Lobmaier I, Bjerkehagen B, Heim S.

Diagn Pathol. 2016 Feb 9;11:22. doi: 10.1186/s13000-016-0472-8.

25.

Fusion of the TBL1XR1 and HMGA1 genes in splenic hemangioma with t(3;6)(q26;p21).

Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S.

Int J Oncol. 2016 Mar;48(3):1242-50. doi: 10.3892/ijo.2015.3310. Epub 2015 Dec 28.

26.

Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience.

Zaikova O, Sundby Hall K, Styring E, Eriksson M, Trovik CS, Bergh P, Bjerkehagen B, Skorpil M, Weedon-Fekjaer H, Bauer HC.

J Surg Oncol. 2015 Dec;112(8):853-60. doi: 10.1002/jso.24074. Epub 2015 Oct 19.

PMID:
26482729
27.

LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13).

Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S.

Cancer Genet. 2015 Nov;208(11):545-51. doi: 10.1016/j.cancergen.2015.07.007. Epub 2015 Aug 3.

PMID:
26432191
28.

The recurrent chromosomal translocation t(12;18)(q14~15;q12~21) causes the fusion gene HMGA2-SETBP1 and HMGA2 expression in lipoma and osteochondrolipoma.

Panagopoulos I, Gorunova L, Bjerkehagen B, Lobmaier I, Heim S.

Int J Oncol. 2015 Sep;47(3):884-90. doi: 10.3892/ijo.2015.3099. Epub 2015 Jul 21.

29.
30.

Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondroma.

Panagopoulos I, Bjerkehagen B, Gorunova L, Taksdal I, Heim S.

Oncol Rep. 2015 Aug;34(2):577-84. doi: 10.3892/or.2015.4035. Epub 2015 Jun 5.

31.

Fusion of the genes EWSR1 and PBX3 in retroperitoneal leiomyoma with t(9;22)(q33;q12).

Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S.

PLoS One. 2015 Apr 14;10(4):e0124288. doi: 10.1371/journal.pone.0124288. eCollection 2015.

32.

Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature.

Berner K, Bjerkehagen B, Bruland ØS, Berner A.

Anticancer Res. 2015 Apr;35(4):2129-40.

PMID:
25862869
33.

[A boy with a wound on his finger that would not heal].

Hompland I, Rizvi SM, Winge M, Norum OJ, Bjerkehagen B, Ringen HO, Taksdal I, Mørk NJ, Hall KS.

Tidsskr Nor Laegeforen. 2015 Mar 10;135(5):445-8. doi: 10.4045/tidsskr.14.0759. eCollection 2015 Mar 10. Norwegian. No abstract available.

34.

Novel KAT6B-KANSL1 fusion gene identified by RNA sequencing in retroperitoneal leiomyoma with t(10;17)(q22;q21).

Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S.

PLoS One. 2015 Jan 26;10(1):e0117010. doi: 10.1371/journal.pone.0117010. eCollection 2015.

35.

[A woman in her 50s with heavy breathing and hypotension].

Hommerstad A, Hall KS, Bjerkehagen B, Eskild TH, Geiran O, Øie E.

Tidsskr Nor Laegeforen. 2014 Sep 30;134(18):1758-61. doi: 10.4045/tidsskr.13.1110. eCollection 2014 Sep 30. Norwegian. No abstract available.

36.

Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification.

Panagopoulos I, Bjerkehagen B, Gorunova L, Berner JM, Boye K, Heim S.

Int J Oncol. 2014 Nov;45(5):1829-36. doi: 10.3892/ijo.2014.2605. Epub 2014 Aug 18.

37.

Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.

Danielsen SA, Lind GE, Kolberg M, Høland M, Bjerkehagen B, Sundby Hall K, van den Berg E, Mertens F, Smeland S, Picci P, Lothe RA.

Neuro Oncol. 2015 Jan;17(1):63-9. doi: 10.1093/neuonc/nou140. Epub 2014 Jul 19.

38.

Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.

Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bøhler PJ, Bruland ØS.

Acta Oncol. 2015 Jan;54(1):25-33. doi: 10.3109/0284186X.2014.923934. Epub 2014 Jun 24.

39.

The "grep" command but not FusionMap, FusionFinder or ChimeraScan captures the CIC-DUX4 fusion gene from whole transcriptome sequencing data on a small round cell tumor with t(4;19)(q35;q13).

Panagopoulos I, Gorunova L, Bjerkehagen B, Heim S.

PLoS One. 2014 Jun 20;9(6):e99439. doi: 10.1371/journal.pone.0099439. eCollection 2014.

40.

Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma.

Panagopoulos I, Gorunova L, Bjerkehagen B, Boye K, Heim S.

Oncol Rep. 2014 Jul;32(1):40-4. doi: 10.3892/or.2014.3180. Epub 2014 May 15.

41.

Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?

Ohnstad HO, Bruland OS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, Jørgensen LH, Hall KS.

Acta Oncol. 2014 Sep;53(9):1180-7. doi: 10.3109/0284186X.2014.899433. Epub 2014 Apr 3.

PMID:
24697744
42.

Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors.

Panagopoulos I, Brandal P, Gorunova L, Bjerkehagen B, Heim S.

Int J Oncol. 2014 May;44(5):1425-32. doi: 10.3892/ijo.2014.2326. Epub 2014 Mar 5.

43.

Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin.

Fløisand Y, Beiske K, Tjønnfjord GE, Heldal D, Bjerkehagen B, Revheim ME, Heim S, Bruland OS, Hall KS, Tierens A, Delabie J.

Case Rep Hematol. 2013;2013:934781. doi: 10.1155/2013/934781. Epub 2013 Dec 17.

44.

Do Not Be Fooled by Fancy Mutations: Inflammatory Fibroid Polyps Can Harbor Mutations Similar to Those Found in GIST.

Bjerkehagen B, Aaberg K, Steigen SE.

Case Rep Med. 2013;2013:845801. doi: 10.1155/2013/845801. Epub 2013 Nov 6.

45.

Incidence and mortality of second sarcomas - a population-based study.

Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Bruland ØS, Smeland S, Johannesen TB, Fosså SD.

Eur J Cancer. 2013 Oct;49(15):3292-302. doi: 10.1016/j.ejca.2013.05.017. Epub 2013 Jun 17.

PMID:
23787025
46.

Multimodal functional imaging for early response assessment in GIST patients treated with imatinib.

Revheim ME, Hole KH, Bruland OS, Reitan E, Bjerkehagen B, Julsrud L, Seierstad T.

Acta Oncol. 2014 Jan;53(1):143-8. doi: 10.3109/0284186X.2013.798428. Epub 2013 May 28. No abstract available.

47.

Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation.

Panagopoulos I, Thorsen J, Gorunova L, Haugom L, Bjerkehagen B, Davidson B, Heim S, Micci F.

Genes Chromosomes Cancer. 2013 Jul;52(7):610-8. doi: 10.1002/gcc.22057. Epub 2013 Apr 12.

PMID:
23580382
48.

Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma.

Nyquist KB, Panagopoulos I, Thorsen J, Haugom L, Gorunova L, Bjerkehagen B, Fosså A, Guriby M, Nome T, Lothe RA, Skotheim RI, Heim S, Micci F.

PLoS One. 2012;7(11):e49705. doi: 10.1371/journal.pone.0049705. Epub 2012 Nov 21.

49.

Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma.

Ohnstad HO, Castro R, Sun J, Heintz KM, Vassilev LT, Bjerkehagen B, Kresse SH, Meza-Zepeda LA, Myklebost O.

Cancer. 2013 Mar 1;119(5):1013-22. doi: 10.1002/cncr.27837. Epub 2012 Nov 16.

50.

Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma.

Panagopoulos I, Micci F, Thorsen J, Gorunova L, Eibak AM, Bjerkehagen B, Davidson B, Heim S.

PLoS One. 2012;7(6):e39354. doi: 10.1371/journal.pone.0039354. Epub 2012 Jun 22.

Supplemental Content

Loading ...
Support Center